Literature DB >> 14645475

Reward without dopamine.

Claire Matson Cannon1, Richard D Palmiter.   

Abstract

Dopamine (DA) is believed to play a fundamental role in reward processes. Virtually all drugs of abuse activate dopaminergic systems, as do "natural" rewards such as sexual interaction and food. Sweet-tasting solutions, for example, are a well characterized natural reward. In the present experiments, we used mice that cannot make DA (DD mice) to test the hypothesis that DA is necessary for reward. Sucrose preference, assessed with a computerized "lickometer," was used to determine whether DD mice respond preferentially for rewarding stimuli. DD mice preferentially chose sucrose over water, and also preferred the noncaloric sweetener saccharin. Furthermore, the rate of licking, bout size, and length were greater in DD mice drinking sweets than in controls. These data refute the necessity of DA for the reward processes manifested by sucrose preference. However, DD mice initiated licking less frequently than control mice and had fewer total licks. We suggest that DD mice have a deficit of goal-directed behavior that is not specific to reward processes. Lastly, juvenile DD mice demonstrate robust sucrose preference before experience with food in the presence of DA. Thus, DA is not required for mice to learn to consume sweet solutions preferentially. We conclude that DA is not required to find the sweet tastes of sucrose or saccharin rewarding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645475      PMCID: PMC6740991     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  101 in total

1.  Nutrient selection in the absence of taste receptor signaling.

Authors:  Xueying Ren; Jozélia G Ferreira; Ligang Zhou; Sara J Shammah-Lagnado; Catherine W Yeckel; Ivan E de Araujo
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  The gut-brain dopamine axis: a regulatory system for caloric intake.

Authors:  Ivan E de Araujo; Jozélia G Ferreira; Luis A Tellez; Xueying Ren; Catherine W Yeckel
Journal:  Physiol Behav       Date:  2012-03-03

3.  Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery.

Authors:  C N Ochner; E Stice; E Hutchins; L Afifi; A Geliebter; J Hirsch; J Teixeira
Journal:  Neuroscience       Date:  2012-02-24       Impact factor: 3.590

Review 4.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

Review 5.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

Review 6.  Architectural Representation of Valence in the Limbic System.

Authors:  Praneeth Namburi; Ream Al-Hasani; Gwendolyn G Calhoon; Michael R Bruchas; Kay M Tye
Journal:  Neuropsychopharmacology       Date:  2015-12-09       Impact factor: 7.853

Review 7.  Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Authors:  Paul E M Phillips; Mark E Walton; Thomas C Jhou
Journal:  Psychopharmacology (Berl)       Date:  2006-11-22       Impact factor: 4.530

8.  Modeling operant behavior in the Parkinsonian rat.

Authors:  Irene Avila; Mark P Reilly; Federico Sanabria; Diana Posadas-Sánchez; Claudia L Chavez; Nikhil Banerjee; Peter Killeen; Eddie Castañeda
Journal:  Behav Brain Res       Date:  2008-11-27       Impact factor: 3.332

Review 9.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

Review 10.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.